Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.
about
Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Anti-Melanoma immunity and loc ...... imiquimod; a phase 2 a trial.
@en
Anti-Melanoma immunity and loc ...... imiquimod; a phase 2 a trial.
@nl
type
label
Anti-Melanoma immunity and loc ...... imiquimod; a phase 2 a trial.
@en
Anti-Melanoma immunity and loc ...... imiquimod; a phase 2 a trial.
@nl
prefLabel
Anti-Melanoma immunity and loc ...... imiquimod; a phase 2 a trial.
@en
Anti-Melanoma immunity and loc ...... imiquimod; a phase 2 a trial.
@nl
P2093
P2860
P1433
P1476
Anti-Melanoma immunity and loc ...... imiquimod; a phase 2 a trial.
@en
P2093
Carel J M van Noesel
Cornelis J M Melief
Cornelis L M C Franken
E Helen Kemp
Esther P M Tjin
Gabrielle Krebbers
Germaine N Relyveld
Hansje-Eva Teulings
J P Wietze van der Veen
Jan W Drijfhout
P2860
P304
P356
10.1080/2162402X.2017.1419113
P577
2018-01-15T00:00:00Z